Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures - Operating Segments (Details)

v3.19.3
Segment Disclosures - Operating Segments (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2019
USD ($)
segment
Sep. 30, 2018
USD ($)
Segment Reporting Information [Line Items]        
Number of reportable segments | segment     2  
Revenue $ 3,319 $ 2,550 $ 10,197 $ 8,036
Cost of revenue 1,569 1,467 5,288 5,217
Gross profit 1,750 1,083 4,909 2,819
Operating Segments        
Segment Reporting Information [Line Items]        
Revenue 3,319 2,550 10,197 8,036
Cost of revenue 1,569 1,467 5,288 5,217
Gross profit 1,750 1,083 4,909 2,819
EksoHealth | Operating Segments        
Segment Reporting Information [Line Items]        
Revenue 2,981 1,744 8,635 6,266
Cost of revenue 1,279 827 3,906 3,699
Gross profit 1,702 917 4,729 2,567
EksoWorks | Operating Segments        
Segment Reporting Information [Line Items]        
Revenue 320 789 1,536 1,742
Cost of revenue 272 618 1,356 1,483
Gross profit 48 171 180 259
Other | Operating Segments        
Segment Reporting Information [Line Items]        
Revenue 18 17 26 28
Cost of revenue 18 22 26 35
Gross profit $ 0 $ (5) $ 0 $ (7)